• Follow
  • Follow
  • Follow
  • Home
  • About
  • Science
  • Pipeline
  • News
  • Investors
  • Publications
  • Contact
  • Follow
  • Follow
  • Follow
  • Home
  • About
  • Science
  • Pipeline
  • News
  • Investors
  • Publications
  • Contact
Meet 2N Pharma at the Anglonordic Life Science Conference

Meet 2N Pharma at the Anglonordic Life Science Conference

by Nicole Overmars | May 3, 2022 | Press Releases

Aalborg – We are pleased to announce that Preben Bruun Nyzell has been invited to the Anglonordic Life Science Conference that takes place in London on May 4-5.   About Anglonordic The Anglonordic Life Science Conference is an investment and partnering...
US Department of Defense awarded 2N Pharma a grant of 944.000 USD

US Department of Defense awarded 2N Pharma a grant of 944.000 USD

by Nicole Overmars | Apr 12, 2022 | Press Releases

Aalborg – US Department of Defense has awarded 2N Pharma a grant of 944.000 USD. 2N Pharma is thrilled to announce that the US Department of Defense has awarded 2N Pharma a grant of 944.000 USD. We are extremely grateful for the financial support that will...
DKBIO 2022 brings together Scandinavian bioscience start-ups with investors

DKBIO 2022 brings together Scandinavian bioscience start-ups with investors

by Nicole Overmars | Apr 5, 2022 | Press Releases

Boston – We are thrilled to announce that Preben Bruun-Nyzell and John Nieland will attend DKBIO 2022 in Boston on April 6-7. About DKBIO Innovation Centre Denmark and the Danish Ministry of Foreign Affairs are hosting DKBIO 2022. One of our investors,...
Neurodegeneration: unique and innovative approach to develop a cure

Neurodegeneration: unique and innovative approach to develop a cure

by Nicole Overmars | Mar 24, 2022 | Press Releases

2N Pharma has big ambitions. Our mission is to do what no one has yet managed: develop effective drugs with our innovative approach for the neurological diseases ALS and Parkinson’s.    Unmet medical need Parkinson’s disease was first described...
Women in STEM: this is why a career in science is so fascinating

Women in STEM: this is why a career in science is so fascinating

by Nicole Overmars | Feb 11, 2022 | Press Releases

On the occasion of today’s International Day of Women and Girls in Science, we spoke with Angelique Corthals, an inspiring woman in STEM. She is a multifaceted scientist, and has years of experience in the fields of metabolic dysfunction and neurological...
2N Pharma will be presenting at BioSeed 2022

2N Pharma will be presenting at BioSeed 2022

by Nicole Overmars | Jan 19, 2022 | Press Releases

AALBORG, Denmark – We are thrilled to announce that 2N Pharma will be a showcase presenter at BioSeed 2022. 2N Pharma will attend BioSeed, OBN’s Early-Stage Life Science Investment Event. The event takes place in London on January 25. Chair Alex Leech, CEO Preben...
« Older Entries

Recent Posts

  • Meet 2N Pharma at the Anglonordic Life Science Conference
  • US Department of Defense awarded 2N Pharma a grant of 944.000 USD
  • DKBIO 2022 brings together Scandinavian bioscience start-ups with investors
  • Neurodegeneration: unique and innovative approach to develop a cure
  • Women in STEM: this is why a career in science is so fascinating

Recent Comments

    2npharma

    2N Pharma is a small biotech company with a big vision: we want to cure ALS and other currently incurable neurodegenerative diseases.

    2N Pharma
    Parkinson's disease has a significant impact on a Parkinson's disease has a significant impact on a person's daily life. Aside from difficulty walking, there are invisible effects that are often underestimated. 

For example, it may become more difficult to absorb information, plan, or focus on something. 

These are less well-known issues, and because they are intangible, they can lead to misunderstandings. That is why it is critical to raise awareness and improve understanding for people suffering from brain disorders. 
.
.
.
#health #publichealth #mentalhealth #neuroscience #parkinsons #ALS #biotech #pharma #lifesciences
    As part of #Memorial Day and #ALS Awareness Month, As part of #Memorial Day and #ALS Awareness Month, we'd like to highlight the connection between ALS and military #veterans. For unknown reasons, veterans have a significantly higher risk of ALS than the civilian population. 

Today we commemorate those who gave their lives while serving in the US military, and we pay special tribute to those who lost their battle with ALS.
.
.
.
#drugdevelopment #drugdiscovery #neuroscience #lifesciences #publichealth #ALSresearch #ALSawareness #biotech #pharma #USmemorialday
    ALS is a rare and progressive #neurological diseas ALS is a rare and progressive #neurological disease that affects people all over the world. Today, over 60.000 people have #ALS, and 20.000 new patients are diagnosed each year.

ALS is fatal, with a life expectancy of only 3-5 years from the beginning of the first symptoms. Despite nearly 150 years of #research, the cause remains unknown, and there is no effective treatment, let alone a cure.

This month, we will be sharing information about ALS and our research. Stay tuned!

#ALSresearch #ALStreatment #neuroscience #lifesciences #publichealth
    Chronic Immunological and Neurological Diseases (# Chronic Immunological and Neurological Diseases (#CIND) is a collective term for a number of diseases that affect both the central nervous and the immune system, including Amyotrophic Lateral Sclerosis (#ALS), and #Parkinsons.

There is currently no effective treatment, let alone a cure, for either ALS or Parkinson’s. Our mission is to develop a novel, therapeutic drug that will improve the quality of life for both patients and their families.
.
.
.
#lifesciences #publichealth #neuroscience #drugdevelopment #ALSawareness #neurodegenerativedisease #research #pharma #biotech
    Load More... Follow on Instagram

    LinkedIn
    Twitter

    About
    Technology
    Pipeline
    News
    Investors
    Publications
    Contact

    Policies, Terms & Conditions
    Website Terms and Conditions
    Data Privacy Policy
    Cookie Policy
    GDPR Compliance
    2N Pharma ApS
    Novi Science Park, Niels Jernes Vej 10, 9220 Aalborg Ø, Denmark
    BioInnovation Institute, Ole Maaløes Vej 3, 2200 København N, Denmark
    CVR: 41169303 VAT: DK41169303 D-U-N-S: 306192737
    email: info@2npharma.com

    2N Pharma Follow

    A small biotech company with a big vision: we want to cure ALS.

    2NPharma
    2npharma 2N Pharma @2npharma ·
    30 Jun

    #Parkinsonsdisease affects daily life. Aside from difficulty walking, there are invisible effects that are often underestimated.

    Intangible issues can lead to misunderstandings. It’s critical to raise awareness and improve understanding for people suffering from #braindisorders.

    Reply on Twitter 1542447854806917121 Retweet on Twitter 1542447854806917121 Like on Twitter 1542447854806917121 Twitter 1542447854806917121
    Load More